Satoshi Matsushita

Dr. Satoshi Matsushita


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2023 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
HMHiroshi Mukaida
Hiroshi Mukaida
SMSatoshi Matsushita
Satoshi Matsushita
TYTaira Yamamoto
Taira Yamamoto
YMYuki Minami
Yuki Minami
GSGo Sato
Go Sato
AAAtsushi Amano
Atsushi Amano

1 August 2019 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
HMHiroshi Mukaida
Hiroshi Mukaida
SMSatoshi Matsushita
Satoshi Matsushita
KKKenji Kuwaki
Kenji Kuwaki
TITakahiro Inotani
Takahiro Inotani
YMYuki Minami
Yuki Minami
AAAtsushi Amano
Atsushi Amano

1 January 2016 in Journal of Tissue Engineering
Verified
Journal Article
Open access
SMSatoshi Matsushita
Satoshi Matsushita
JFJames S Forrester
James S Forrester
CLChuan Li
Chuan Li
MSMitsuru Sato
Mitsuru Sato
ZLZhengqing Li
Zhengqing Li
AAAtsushi Amano
Atsushi Amano
The lack of cell retention clearly represents a potentially serious limitation for therapeutic efficacy of stem cells. To enhance the efficacy, we developed a novel hydrogel that is thermosensitive and biodegradable and possesses desirable stiffness in a solid form. Immediately after induction of myocardial infarction of male rat, cardiac outgrowth cells embedded in hydrogel (HG) or saline (CO) were injected directly into the peri-infarct area. Left ventricular ejection fraction, cell retention rate, and a spectrum of biochemical markers were measured to evaluate the effect of the treatment. Left ventricular ejection fraction was significantly higher in the cell-injected groups (HG and CO) than in the control group at 1 week after treatment. This functional benefit was continued only in the HG group, accompanied with more retained cells. Furthermore, the expression of insulin-like growth factor-1 was significantly higher in the HG group with less progression of cell apoptosis.

14 February 2012 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
KKKenji Kuwaki
Kenji Kuwaki
AAAtsushi Amano
Atsushi Amano
HIHirotaka Inaba
Hirotaka Inaba
TYTaira Yamamoto
Taira Yamamoto
TMTakeshi Matsumura
Takeshi Matsumura
SMSatoshi Matsushita
Satoshi Matsushita
Background: The purpose of this study was to evaluate clinical risk factors and assess the impact of the Society of Thoracic Surgeons (STS) scores on outcomes after contemporary aortic valve replacement (AVR) for aortic stenosis (AS). Methods: We retrospectively analyzed the data from 209 consecutive patients with AS (mean 69 ± 9 years) who underwent AVR. The outcomes measured included operative mortality, postoperative complications, postoperative prolonged length of stay (PLOS), discharge to nonhome location, and mid‐term mortality. Results: Operative mortality was 3.8%, and five‐year survival was 88.6 ± 2.8%. Multivariable analysis revealed preoperative New York Heart Association (NYHA) class as a significant predictor of both operative mortality (p = 0.03; odds ratio [OR]: 8.5) and mid‐term mortality (p = 0.02; OR: 10.5). NYHA class also emerged as an independent predictor for postoperative complications (p = 0.002; OR: 5.8) and PLOS (p = 0.01; OR: 2.5). Other preoperative independent predictors included dialysis for PLOS (p = 0.04; OR: 2.9), age (p = 0.03; OR: 1.1), and left ventricular ejection fraction (EF; p = 0.03; OR: 0.9) for nonhome discharge, and EF for mid‐term mortality (p = 0.01; OR: 0.9). The mean STS‐PROM (predicted risk of mortality) was 4.6% ± 6.1%, and thus, the observed‐to‐expected (O/E) ratio of operative mortality in our series was 0.82. Conclusions: Advanced NYHA class, older age, dialysis, and lower EF are significant independent preoperative risk factors for early and mid‐term results of AVR for AS. Consideration of these predictors should be used to identify high‐risk patients requiring AVR for AS.

13 September 2016 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
TKTomoko S. Kato
Tomoko S. Kato
HNHiroshi Nakamura
Hiroshi Nakamura
MMMai Murata
Mai Murata
KKKishio Kuroda
Kishio Kuroda
HSHitoshi Suzuki
Hitoshi Suzuki
AAAtsushi Amano
Atsushi Amano
Adequate fluid management is an important component of patient care following cardiac surgery. Our aim in this study was to determine the benefits of tolvaptan, an oral selective vasopressin-2 receptor antagonist that causes electrolyte-free water diuresis, in postoperative fluid management. We prospectively examined the effect of tolvaptan on renal excretion of electrolytes and urea nitrogen in cardiac surgery patients. Patients undergoing coronary artery bypass surgery were randomized to receive conventional loop diuretics (Group C, n = 30) or conventional loop diuretic therapy plus tolvaptan (Group T, n = 27). Fractional excretions of sodium (FENA), potassium (FEK) and urea nitrogen (FEUN) were measured in both groups during post-surgical hospitalization. Urine output was greater with tolvaptan (Group T) than without it (Group C), and some patients in Group C required intravenous as well as oral loop diuretics. Serum sodium concentrations decreased after surgery in Group C, but were unchanged in Group T (postoperative day [POD] 3, 139.8 ± 3.5 vs. 142.3 ± 2.6 mEq/L, p = 0.006). However, postoperative FENA values in Group C did not decrease, and the values were similar in both groups. Serum potassium levels remained lower and FEK values remained higher than the preoperative values, but only in Group C (all p < 0.05). BUN increased postoperatively in both groups, but it remained higher than its preoperative value only in Group C (all p < 0.01). Group T showed an initial increase in BUN, which peaked and then returned to its preoperative value within a week. The FEUN increased postoperatively in both groups, but the change was more pronounced in Group T (POD7, 52.7 ± 9.3 vs. 58.2 ± 6.5 %, p = 0.025). Renal excretion of sodium and potassium reflects the changes in serum concentration in patients treated with tolvaptan. Patients treated only with loop diuretics showed a continuous excretion of sodium and potassium that led to electrolyte imbalance, whereas the combination of loop diuretics and tolvaptan increased renal urea nitrogen elimination. Tolvaptan therefore appears to be an effective diuretic that minimally affects serum electrolytes while adequately promoting the elimination of urea nitrogen from the kidneys in patients undergoing coronary artery bypass surgery. The present study is registered with the UMIN Clinical Trials Registry (ID: UMIN000011039 )

1 March 2014 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
YYYasutaka Yokoyama
Yasutaka Yokoyama
SMSatoshi Matsushita
Satoshi Matsushita
TITakafumi Iesaki
Takafumi Iesaki
TYTaira Yamamoto
Taira Yamamoto
HIHirotaka Inaba
Hirotaka Inaba
AAAtsushi Amano
Atsushi Amano